Document Detail


Pregnancy in primary sclerosing cholangitis.
MedLine Citation:
PMID:  21339205     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background There is a paucity of data on fertility or pregnancy in patients with primary sclerosing cholangitis (PSC). Objective To assess fertility in PSC by comparing the number of children in a large cohort of PSC patients to healthy controls and to investigate the outcome of pregnancy, as well as the influence of pregnancy on the disease course. Design Case series. Setting Germany. Participants 229 PSC patients and 569 healthy controls were evaluated for the number of children. 17 patients with PSC and at least one pregnancy, or who received a diagnosis of PSC within 6&emsp14;months after delivery, were included in the more detailed analysis. Main outcome measures Number of children per patient and control; disease activity during pregnancy and after delivery including maternal complications; long-term development of live births, fetal loss rate and the influence of medication on fetal and maternal outcome. Results Fertility did not seem to be reduced in PSC since the number of children did not differ between PSC patients and healthy controls. 25 pregnancies in 17 female PSC patients (median age at conception 31&emsp14;years) were investigated in detail. An increase in liver enzymes was documented during five pregnancies (20%) and eight times (32%) post-partum. There were no serious maternal complications. All 21 live births presented with a normal perinatal and postnatal development over a median observation time of 50 months. Two pregnancies were delivered pre-term and four fetal losses occurred early in pregnancy (<12 wk). Continuation of treatment with ursodeoxycholic acid (15/21) or azathioprine (2/21) had no negative effects on pregnancy outcome. Conclusions Fertility does not seem to be reduced in patients with PSC, who are able to deliver healthy children without an apparent increase in risk for mother or child.
Authors:
Björn E Wellge; Martina Sterneck; Andreas Teufel; Christian Rust; Andre Franke; Stefan Schreiber; Thomas Berg; Rainer Günther; Wolfgang Kreisel; Christine Zu Eulenburg; Felix Braun; Ulrich Beuers; Peter R Galle; Ansgar W Lohse; Christoph Schramm
Related Documents :
15591085 - Day 14 maternal serum progesterone levels predict pregnancy outcome in ivf/icsi treatme...
2203805 - The effects of the antiprogestin mifepristone, in vivo, and progesterone in vitro on pr...
21366395 - The effect of maternal obesity on pregnancy outcomes in women with gestational diabetes.
21466515 - Maternal and perinatal health outcomes by body mass index category.
11322605 - Shifting gustatory thresholds and food cravings during pregnancy as expanding uterine-i...
25330815 - Is it safe to use smoking cessation therapeutics during pregnancy?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-21
Journal Detail:
Title:  Gut     Volume:  -     ISSN:  1468-3288     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985108R     Medline TA:  Gut     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.
Next Document:  Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-...